JP2010534646A5 - - Google Patents

Download PDF

Info

Publication number
JP2010534646A5
JP2010534646A5 JP2010517535A JP2010517535A JP2010534646A5 JP 2010534646 A5 JP2010534646 A5 JP 2010534646A5 JP 2010517535 A JP2010517535 A JP 2010517535A JP 2010517535 A JP2010517535 A JP 2010517535A JP 2010534646 A5 JP2010534646 A5 JP 2010534646A5
Authority
JP
Japan
Prior art keywords
aza
bicyclo
hex
methyl
ylmethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010517535A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010534646A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2008/052985 external-priority patent/WO2009016560A2/en
Publication of JP2010534646A publication Critical patent/JP2010534646A/ja
Publication of JP2010534646A5 publication Critical patent/JP2010534646A5/ja
Pending legal-status Critical Current

Links

JP2010517535A 2007-07-27 2008-07-25 トランス−3−アザ−ビシクロ[3.1.0]ヘキサン誘導体 Pending JP2010534646A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IB2007052987 2007-07-27
IB2008051167 2008-03-28
PCT/IB2008/052985 WO2009016560A2 (en) 2007-07-27 2008-07-25 Trans-3-aza-bicyclo[3.1.0]hexane derivatives

Publications (2)

Publication Number Publication Date
JP2010534646A JP2010534646A (ja) 2010-11-11
JP2010534646A5 true JP2010534646A5 (index.php) 2011-09-01

Family

ID=40130778

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010517535A Pending JP2010534646A (ja) 2007-07-27 2008-07-25 トランス−3−アザ−ビシクロ[3.1.0]ヘキサン誘導体

Country Status (8)

Country Link
EP (1) EP2185512B1 (index.php)
JP (1) JP2010534646A (index.php)
CN (1) CN101790515A (index.php)
AT (1) ATE493386T1 (index.php)
CA (1) CA2693817A1 (index.php)
DE (1) DE602008004265D1 (index.php)
TW (1) TW200904799A (index.php)
WO (1) WO2009016560A2 (index.php)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101522618A (zh) * 2006-09-29 2009-09-02 埃科特莱茵药品有限公司 3-氮杂-双环[3.1.0]己烷衍生物
WO2008150364A1 (en) 2007-05-23 2008-12-11 Merck & Co., Inc. Cyclopropyl pyrrolidine orexin receptor antagonists
EP2275421A1 (en) 2009-07-15 2011-01-19 Rottapharm S.p.A. Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction
MX2012004990A (es) 2009-10-30 2012-06-12 Janssen Pharmaceutica Nv Deribados de imidazo [1,2-b] pirimideazina y su uso como inhibidores de la enzima fosfodiesterasa 10.
KR20130005263A (ko) 2009-12-30 2013-01-15 아르퀼 인코포레이티드 치환된 나프탈레닐-피리미딘 화합물
AR080754A1 (es) 2010-03-09 2012-05-09 Janssen Pharmaceutica Nv Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10
EP2675801B1 (en) 2011-02-18 2015-04-08 Actelion Pharmaceuticals Ltd. Novel pyrazole and imidazole derivatives useful as orexin antagonists
AU2012277912B2 (en) 2011-06-27 2017-03-23 Janssen Pharmaceutica Nv 1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivatives
EA201400138A1 (ru) 2011-07-15 2014-06-30 Басф Се Пестицидные способы применения замещенных 3-пиридилтиазольных соединений и производных для борьбы с животными-вредителями ii
CN104220065A (zh) 2012-02-07 2014-12-17 Eolas治疗公司 取代的脯氨酸/哌啶用作食欲素受体拮抗剂
US9440982B2 (en) 2012-02-07 2016-09-13 Eolas Therapeutics, Inc. Substituted prolines/piperidines as orexin receptor antagonists
ITMI20120322A1 (it) 2012-03-01 2013-09-02 Rottapharm Spa Composti di 4,4-difluoro piperidina
ES2617863T3 (es) 2012-06-04 2017-06-20 Actelion Pharmaceuticals Ltd. Derivados de bencimidazol-prolina
EP2863909B1 (en) 2012-06-26 2020-11-04 Janssen Pharmaceutica N.V. Combinations comprising 4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline compounds as pde 2 inhibitors and pde 10 inhibitors for use in the treatment of neurological or metabolic disorders
EP2869822B1 (en) 2012-07-09 2016-09-14 Janssen Pharmaceutica, N.V. Inhibitors of phosphodiesterase 10 enzyme
BR112015001201B1 (pt) * 2012-07-18 2022-02-22 University Of Notre Dame Du Lac Compostos anti-infecciosos 5,5-heteroaromáticos e composição
US9493446B2 (en) 2012-10-10 2016-11-15 Actelion Pharmaceuticals Ltd. Orexin receptor antagonists which are [ortho bi-(hetero-)aryl]-[2-(meta bi-(hetero-)aryl)-pyrrolidin-1-yl]-methanone derivatives
CA2902135A1 (en) 2013-03-12 2014-09-18 Actelion Pharmaceuticals Ltd Azetidine amide derivatives as orexin receptor antagonists
UA119151C2 (uk) 2013-12-03 2019-05-10 Ідорсія Фармасьютікалз Лтд КРИСТАЛІЧНА СОЛЬОВА ФОРМА (S)-(2-(6-ХЛОР-7-МЕТИЛ-1H-БЕНЗО[d]ІМІДАЗОЛ-2-ІЛ)-2-МЕТИЛПІРОЛІДИН-1-ІЛ)(5-МЕТОКСИ-2-(2H-1,2,3-ТРИАЗОЛ-2-ІЛ)ФЕНІЛ)МЕТАНОНУ ЯК АНТАГОНІСТ ОРЕКСИНОВОГО РЕЦЕПТОРА
TWI664177B (zh) 2013-12-03 2019-07-01 瑞士商愛杜西亞製藥有限公司 晶形
EA029725B1 (ru) 2013-12-04 2018-05-31 Идорсиа Фармасьютиклз Лтд Применение производных бензимидазолпролина
EP3180332B1 (en) 2014-08-13 2021-10-27 Eolas Therapeutics Inc. Difluoropyrrolidines as orexin receptor modulators
WO2017139603A1 (en) 2016-02-12 2017-08-17 Astrazeneca Ab Halo-substituted piperidines as orexin receptor modulators
WO2020007964A1 (en) 2018-07-05 2020-01-09 Idorsia Pharmaceuticals Ltd 2-(2-azabicyclo[3.1.0]hexan-1-yl)-1h-benzimidazole derivatives
WO2020099511A1 (en) 2018-11-14 2020-05-22 Idorsia Pharmaceuticals Ltd Benzimidazole-2-methyl-morpholine derivatives
MX2023001818A (es) 2020-08-13 2023-03-13 Boehringer Ingelheim Int Compuestos para usarse en tratamiento de deterioro cognitivo asociado con la esquizofrenia.
AU2021360172A1 (en) 2020-10-13 2023-03-30 Boehringer Ingelheim International Gmbh Process of reworking
CN116783182B (zh) * 2021-02-02 2025-08-29 南京明德新药研发有限公司 四氢吡咯并环化合物及其应用
TW202400149A (zh) 2022-05-13 2024-01-01 瑞士商愛杜西亞製藥有限公司 經噻唑并芳基-甲基取代之環狀肼-n-甲醯胺衍生物
WO2025224168A1 (en) 2024-04-24 2025-10-30 Idorsia Pharmaceuticals Ltd Aryl sulfone and sulfanone derivatives as orexin receptor modulators

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130335D0 (en) * 2001-12-19 2002-02-06 Smithkline Beecham Plc Compounds
ES2273083T3 (es) * 2002-09-18 2007-05-01 Glaxo Group Limited N-aroilaminas ciclicas como antagonistas de los receptores de orexina.
CN101522618A (zh) * 2006-09-29 2009-09-02 埃科特莱茵药品有限公司 3-氮杂-双环[3.1.0]己烷衍生物

Similar Documents

Publication Publication Date Title
JP2010534646A5 (index.php)
ES2350460T3 (es) Derivados de 3-aza-biciclo[3.1.0]hexano.
RU2010138640A (ru) Производные 2-аза-бицикло [2.2.1] гептана
CN101568536B (zh) 作为食欲素受体拮抗剂的2-氮杂-双环[3.1.0]己烷衍生物
US8063099B2 (en) Trans-3-aza-bicyclo[3.1.0]hexane derivatives
EP2185512B1 (en) Trans-3-aza-bicyclo[3.1.0]hexane derivatives
JP2010534647A5 (index.php)
JP5934403B2 (ja) 5,6−ジヒドロ−1h−ピリジン−2−オン化合物
JP2010536740A5 (index.php)
JP2010514751A5 (index.php)
JP2007519694A5 (index.php)
JP2010504957A5 (index.php)
KR20160142334A (ko) 시클로프로판아민 화합물 및 이의 용도
CA2729985A1 (en) Thiazolidine compounds as orexin receptor antagonists
CN101501039A (zh) 吡咯并[1,2-b]哒嗪酮化合物
CN108463461A (zh) 头孢烯化合物、其制备和用途
RU2010103322A (ru) Соединения 3-аза-бицикло[3.3.0]октана
IL307868A (en) Compounds for use in the treatment of hyperproliferative disorders
HK1136554B (en) 2-aza-bicyclo[3.1.0]hexane derivatives as orexin receptor antagonists
HK1201822B (en) Process for the preparation of 5,6-dihydro-1h-pyridin-2-one compounds